Literature DB >> 26678363

Systematic Literature Review of Risk Factors and Treatments for Ulcerative Dermatitis in C57BL/6 Mice.

Jennifer L Sargent1, Nathan J Koewler2, Helen E Diggs3.   

Abstract

Ulcerative dermatitis (UD) in C57BL/6 mice is poorly understood and challenging to treat. We sought to evaluate the evidence regarding commonly cited risk factors for UD and reported UD treatments. The terms 'ulcerative dermatitis' and 'C57BL/6' were used to search 3 electronic databases. The resulting 347 articles were screened to identify publications that compared the risk of spontaneous UD in wild-type C57BL/6 mice according to sex, season, diet, or age and those that compared the degree of healing or rate of lesion resolution according to the intervention used. Articles were evaluated by using published criteria for assessing methodologic quality, including study design, number of animals per study group, case definition, method of diagnosis, randomization, enrollment criteria, exclusion criteria, and outcomes. The search identified 11 publications on risk factors that met the inclusion criteria, and no publication on UD treatment met all of the criteria. Relaxing the inclusion criteria for reporting of risk factors and treatment outcomes to include both wild-type C57BL/6 mice and genetically engineered mice on a B6 background yielded 12 publications on risk factors and 3 publications on treatment. Dietary factors, particularly caloric restriction, appear to influence UD risk. Female sex was inconsistently associated with a higher risk of UD, which most often occurred in 13- to 24-mo-old mice in the studies that were reviewed. Only 1 of the 3 publications that evaluated UD treatments included an untreated group or alternative therapy control. Further research is needed to explore epidemiologic aspects of UD and to compare treatment options.

Entities:  

Mesh:

Year:  2015        PMID: 26678363      PMCID: PMC4681240     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  24 in total

1.  Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

Authors:  C Kilkenny; W J Browne; I C Cuthill; M Emerson; D G Altman
Journal:  Osteoarthritis Cartilage       Date:  2012-04       Impact factor: 6.576

2.  Primary follicular dystrophy with scarring dermatitis in C57BL/6 mouse substrains resembles central centrifugal cicatricial alopecia in humans.

Authors:  J P Sundberg; D Taylor; G Lorch; J Miller; K A Silva; B A Sundberg; D Roopenian; L Sperling; D Ong; L E King; H Everts
Journal:  Vet Pathol       Date:  2010-09-22       Impact factor: 2.221

3.  Nutritional up-regulation of serotonin paradoxically induces compulsive behavior.

Authors:  Brett D Dufour; Olayiwola Adeola; Heng-Wei Cheng; Shawn S Donkin; Jon D Klein; Edmond A Pajor; Joseph P Garner
Journal:  Nutr Neurosci       Date:  2010-12       Impact factor: 4.994

4.  Survival characteristics and age-adjusted disease incidences in C57BL/6 mice fed a commonly used cereal-based diet modulated by dietary restriction.

Authors:  Angelo Turturro; Peter Duffy; Bruce Hass; Ralph Kodell; Ronald Hart
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-11       Impact factor: 6.053

5.  Epidermal Fatty Acid binding protein promotes skin inflammation induced by high-fat diet.

Authors:  Yuwen Zhang; Qiang Li; Enyu Rao; Yanwen Sun; Michael E Grossmann; Rebecca J Morris; Margot P Cleary; Bing Li
Journal:  Immunity       Date:  2015-05-19       Impact factor: 31.745

6.  The blessings and curses of C57BL/6 substrains in mouse genetic studies.

Authors:  Camron D Bryant
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

Review 7.  Risk factors for equine laminitis: a systematic review with quality appraisal of published evidence.

Authors:  Claire E Wylie; Simon N Collins; Kristien L P Verheyen; J Richard Newton
Journal:  Vet J       Date:  2011-11-21       Impact factor: 2.688

8.  Ulcerative dermatitis in C57BL/6 mice lacking stearoyl CoA desaturase 1.

Authors:  Lisa Krugner-Higby; Richard Brown; Matthew Rassette; Melissa Behr; Ogi Okwumabua; Mark Cook; Cynthia Bell; Matthew T Flowers; James Ntambi; Annette Gendron
Journal:  Comp Med       Date:  2012-08       Impact factor: 0.982

9.  Creatine improves health and survival of mice.

Authors:  A Bender; J Beckers; I Schneider; S M Hölter; T Haack; T Ruthsatz; D M Vogt-Weisenhorn; L Becker; J Genius; D Rujescu; M Irmler; T Mijalski; M Mader; L Quintanilla-Martinez; H Fuchs; V Gailus-Durner; M Hrabé de Angelis; W Wurst; J Schmidt; T Klopstock
Journal:  Neurobiol Aging       Date:  2007-04-09       Impact factor: 4.673

10.  The Association of Early Dietary Supplementation with Vitamin E with the Incidence of Ulcerative Dermatitis in Mice on a C57BL/6 Background: Diet and Ulcerative Dermatitis in Mice.

Authors:  J R Mader; M A Mason; L K Bale; N M Gades; C A Conover
Journal:  Scand J Lab Anim Sci       Date:  2010       Impact factor: 0.364

View more
  4 in total

1.  Differential Hairless Mouse Strain-Specific Susceptibility to Skin Cancer and Sunburn.

Authors:  Anita Y Voigt; Michael Michaud; Kenneth Y Tsai; Julia Oh; John P Sundberg
Journal:  J Invest Dermatol       Date:  2019-02-08       Impact factor: 8.551

2.  Systematic Literature Review of Risk Factors and Treatments for Ulcerative Dermatitis in C57BL/6 Mice.

Authors:  David K Chu; Sean C Adams; Stephen A Felt; Jerome Geronimo; Joseph P Garner
Journal:  Comp Med       Date:  2016-04       Impact factor: 0.982

3.  Evaluation of Treatment Options for Ulcerative Dermatitis in the P Rat.

Authors:  Beth A Skiles; Chris A Boehm; Jessica L Peveler; Debra L Hickman
Journal:  J Am Assoc Lab Anim Sci       Date:  2021-05-03       Impact factor: 1.232

4.  Weight Cycling Increases Longevity Compared with Sustained Obesity in Mice.

Authors:  Daniel L Smith; Yongbin Yang; Tim R Nagy; Amit Patki; Joseph R Vasselli; Yiying Zhang; Stephanie L Dickinson; David B Allison
Journal:  Obesity (Silver Spring)       Date:  2018-11       Impact factor: 5.002

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.